Detailed Narrative
IDR Process and Regulatory Environment
The quarter saw significant developments in the Independent Dispute Resolution (IDR) process. Federal courts in multiple states issued rulings reinforcing the finality of IDR awards and limiting insurers' ability to challenge arbitration outcomes. Additionally, CMS and other federal agencies released final IDR rules on May 28, 2026, aimed at improving efficiency and transparency, including reducing the administrative fee from $115 to $15 per dispute. These changes are viewed as constructive for providers and are expected to streamline the process, underscoring CMS's intent for IDR to remain a key mechanism for fair reimbursement.
Halo MD Contract Amendment
Nutex Health announced an amendment to its contract with Halo MD, shifting the fee structure to a 'pay on collected' basis, retroactive to the original agreement in 2024. This change, along with a favorably amended service fee structure for net settlement amounts, is expected to significantly reduce arbitration-related costs. The amendment also grants Nutex the flexibility to perform dispute resolution services in-house or use other third-party vendors for future facilities, providing greater control and cost management.
Hospital Development and Growth Pipeline
The company is actively pursuing a de novo hospital development strategy, internalizing real estate capabilities for better control over time⏳lines and costs. The current pipeline for 2026 includes new hospitals in West Little Rock, Arkansas; San Antonio, Texas; and Jacksonville, Florida, all expected to open in Q3 and Q4. For 2027, projects are planned in South, Central, and East Florida, as well as Oklahoma, with two initially owned and developed by Nutex. Beyond 2027, additional Nutex-owned and led projects are approved in Idaho, Florida, Pennsylvania, Ohio, and Arkansas, demonstrating a clear roadmap for long-term growth.
Operational Performance and Patient Experience
Operational performance was strong, with total hospital visits increasing 6.2% to nearly 100,000 for the first half of 2026, and same-hospital visits growing 6.3% in Q2. The company continues to expand patient access and service lines, including the launch of endoscopy services. Patient satisfaction remains high, with an average Google rating of 4.8 stars across over 2,300 reviews. Employee turnover was low at 6.8% for the first half of 2026, significantly below industry benchmarks, contributing to consistent execution and high-quality patient care.
Population Health Division Progress
The Population Health Management division now oversees nearly 40,000 patients, including Medicare Advantage, commercial, and Medicaid managed care members. Revenue for the division grew 15% for the first half of 2026. Independent Physician Associations (IPAs) in Southern California, Houston, and Phoenix were profitable, while South Florida was slightly cash flow negative. New IPAs in Dallas and San Antonio are contracting physicians and will begin enrolling patients in 2027, aiming to build strong partnerships and leverage existing hospital infrastructure.
Revenue Per Visit Dynamics
The decrease in Q2 and H1 2026 revenue was primarily attributed to a larger positive increase in revenue recognized in H1 2025. This was due to adjustments in the collection percentage from 65% to 75% as historical collection data became available. With the collection percentage now stabilized at just over 80%, fewer such positive adjustments are recognized in 2026, leading to a more normalized revenue per visit. The cumulative net revenue per visit since the IDR process began in July 2024 has been consistent at $4,000 to $4,200.